Cilcare
Preclinical auditory research and drug-development services for pharmaceutical, biotech and medical-device partners
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-30
About Cilcare
Cilcare provides preclinical research services and develops therapies and auditory analytics for hearing disorders. Its work includes pharmacokinetic, efficacy, safety and biomarker studies, as well as research into treatments for conditions such as hearing loss, tinnitus and ototoxicity.
Customers include pharmaceutical and biotech companies, medical-device developers, and academic research institutions. Cilcare also has a portfolio of proprietary drug candidates and co-developed programs.
Founded in 2014, the company is headquartered in Montpellier and lists locations in Boston, Paris and Tokyo. It launched an observational clinical trial in diabetic patients in 2023 and is hiring an in vivo technician for preclinical research.
Product: Preclinical auditory research services, proprietary drug candidates, and auditory analytics for hearing disorders.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France. From EU award notices (TED) that name Cilcare by its registry number.
- 17 Dec 2025 UNIVERSITE DE CAEN NORMANDIE · Evaluation dans un modèle murin d’un agent anti-Alzheimer notice
Jobs at Cilcare (1)
Cilcare is hiring for one role.
In vivo Technician – Preclinical Research
New on Evolc
Leadership
- Celia BELLINE · CEOSource: company website
More biotech & pharma companies
Corwave
Heart-assist pumps for heart failure patients, developed by a Paris-area medical device company in clinical stageNew on EvolcRemote-friendlyCrossject
Needle-free auto-injector ZENEO® and emergency drug candidates for epilepsy, adrenal crisis and anaphylaxisNew on EvolcCure 51
Cancer target discovery platform using exceptional survivor biology for pharmaceutical and oncology research partnersYoung companyNew on EvolcCytoo
Muscle disease drug-discovery services and micropattern products for pharmaceutical, biotechnology and research organizationsNew on EvolcDBV Technologies
Develops VIASKIN epicutaneous immunotherapy patches for patients with food allergies and other immunological diseasesNew on EvolcDeeplife
AI-driven cell digital twins and multi-omics analysis for pharmaceutical drug discovery and developmentNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- Google Analytics 4
- Vue
- WooCommerce
- WordPress
- jQuery
